Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,904 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07547540RecruitingPhase 1
Study of an investigational drug for heart failure
This study tests an experimental drug called LY3971297 to see if it can help people with chronic heart failure. It aims to find out if the drug is safe and if it improves heart function.
Detroit, MichiganAges 18–65 - NCT07545564Enrolling by invitationPhase 4
Immune Response Study of Nasal Flu Vaccine in Children
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
Hohhot, Inner MongoliaAges 3–17 - NCT07543796RecruitingPhase 2
Pain Relief After Hip Replacement Surgery
This study tests whether a new pain medication called TRD205 works well and is safe for people recovering from hip replacement surgery. If it works, it could offer better pain control after your operation.
Guangzhou, GuangdongAges 18–80 - NCT07547995RecruitingPhase 2
A study of a new drug for active uveitis
This study tests a new drug (GenSci048) for people with active, non-infectious uveitis in the middle or back of the eye, who are already taking oral steroids. The goal is to see if the drug can better control inflammation and reduce the need for steroids.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07545772RecruitingPhase 2
Testing Brenipatide for Constipation-Focused IBS
This trial tests a new medicine called brenipatide to see if it can help people with IBS-C (irritable bowel syndrome with constipation). The study focuses on whether the drug reduces belly pain and improves bowel movements in people whose main symptom is hard or infrequent stools.
Mesa, ArizonaAges 18–75 - NCT07547813RecruitingPhase 2
Testing LAD328 for moderate-to-severe hidradenitis suppurativa
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
Warsaw, Masovian VoivodeshipAges 18–65 - NCT07545759RecruitingPhase 2
Testing brenipatide for IBS with diarrhea symptoms
This study tests whether a new medication called brenipatide can help people with IBS-diarrhea (IBS-D) reduce belly pain and loose stools. IBS-D is a condition where the intestines move too quickly, causing frequent diarrhea and discomfort.
Mesa, ArizonaAges 18–75 - NCT07551167RecruitingPhase 1
Safety Study of HRS-5765 in Healthy Adults
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
Beijing, Beijing MunicipalityAges 18–65 - NCT07546929RecruitingPhase 2
HP-211 Safety Study for Type 2 Diabetes Treatment
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
Canoga Park, CaliforniaAges 18 years+ - NCT07543536RecruitingPhase 3
Megestrol Acetate for Fatigue in HER2+ Breast Cancer
This study tests whether a medication called megestrol acetate can help reduce severe tiredness and fatigue in people with advanced breast cancer who are receiving a targeted therapy called T-DXd (trastuzumab deruxtecan). Fatigue is a common side effect that can really impact quality of life.
Guangzhou, GuangdongAges 18–75 - NCT07550140Recruiting
Brain Imaging Study on Diet and Thinking in Older Adults
This study looks at how diet affects thinking and memory in people aged 60–80 who have mild memory concerns. Researchers will use brain imaging (MRI scans) to see if certain foods or nutrients help protect brain health.
Reading, BerkshireAges 60–80 - NCT07544667Recruiting
Poly-L-Lactic Acid Injections for Vaginal Tissue Support
This trial tests whether injections of a biocompatible filler (Poly-L-Lactic Acid, also called Sculptra) can help reduce bulging or heaviness in the vaginal area caused by pelvic organ prolapse. The filler is designed to strengthen vaginal tissue and may improve symptoms without surgery.
Durham, North CarolinaAges 21 years+ - NCT07548385RecruitingPhase 3
New pain medicine for after knee replacement surgery
This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.
New York, New YorkAges 18–85 - NCT07545720RecruitingPhase 2
Pinoxin to prevent radiation skin damage
This study tests whether a protective agent called Pinoxin can prevent or reduce skin damage from radiation therapy. If you're getting radiation treatment for cancer, this trial may help protect your skin during therapy.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07551141Recruiting
Vibration to Help Stroke Recovery: Balance and Walking
This study tests whether vibrations applied to the bottom of your feet can help improve walking and balance after stroke. You'll receive plantar vibration therapy (gentle vibrations under your feet) while performing walking and balance exercises to see if it helps your recovery.
BoluAges 18–75 - NCT07545538Enrolling by invitation
Carbohydrate Drink Before Surgery to Help Kids Recover
This study tests whether drinking a special carbohydrate solution before surgery helps children's bodies handle the stress of the operation better and recover more smoothly. The drink may reduce complications related to blood sugar control after surgery.
Yogyakarta, Special Region of YogyakartaAges 2–16 - NCT07549295Enrolling by invitationPhase 1
Melatonin to help babies grow better in the womb
This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.
Shanghai, Shanghai MunicipalityAges 20–43 - NCT07543562RecruitingPhase 3
Selenium supplement for heart failure patients
This study tests whether taking selenium (a mineral supplement) helps heart failure patients feel better and live longer. Researchers will follow patients over time to see if selenium reduces symptoms and hospital visits.
OsloAges 18 years+ - NCT04869098Recruiting
Evening protein shake for night shift workers’ metabolic health
This study tests whether eating a protein preload in the evening (often called a protein “shake/meal” before sleep) can improve metabolic health in night shift workers. It aims to see if this timing and protein intake helps measures related to metabolism while working nights.
Adelaide, South AustraliaAges 35–65 - NCT06635226RecruitingPhase 1
Safety study of ID110521156 in healthy adults
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
SeoulAges 19–50 - NCT04214990RecruitingPhase 3
Aspirin after early stomach precancer or early cancer removal
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
BusanAges 19–70 - NCT05762211RecruitingPhase 2
Oral probiotic to prevent complications after stem-cell transplant
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
AntwerpAges 50 years+ - NCT06359782RecruitingPhase 2
Testing C1-inhibitor for brain bleed after aneurysm
This trial tests a drug called C1-inhibitor (a protein that calms inflammation) given shortly after a bleeding stroke caused by an aneurysm. The goal is to see if it can reduce brain damage and improve recovery.
The Hague, South HollandAges 18 years+ - NCT06020716RecruitingPhase 4
Antibiotics for chronic wet cough in toddlers
This study tests whether the antibiotic Augmentin helps children aged 9 months to 3 years with long-lasting wet cough (more than 4 weeks). It aims to find better ways to treat and understand this common problem in toddlers.
ÅlesundAges 9 months–3 years
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,904 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.